Papers › Effective dose fractionation schemes of radiotherapy for prostate cancer
Effective dose fractionation schemes of radiotherapy for prostate cancer
Jose Alvarez, Kathleen M. Storey, Pavitra Kannan, Heyrim Cho
The archive published only this paper's code-link row. Authors, date and abstract are from arXiv's metadata (CC0), read from the Kaggle arXiv metadata snapshot of 2026-09-12 where its title matched the archive's; the title is the archive's.
Radiation therapy has remained as one of the main cancer treatment modalities and a highly cost-effective single modality treatment of cancer care. Typical regimens for fractionated external beam radiotherapy comprise a constant dose administered on weekdays, and no radiation on weekends. However, every patient has a tumor with distinct properties depending on intra-tumor heterogeneity, aggressiveness, and interactive properties with other cells that may make it more resistant or sensitive to radiation treatment. Accordingly, the concept of personalized cancer treatment is emerging to specialize each patient treatment case to the unique properties of the tumor. In this paper, we examine adaptive radiation treatment strategies for heterogeneous tumors using a dynamical system model that consists of radiation-resistant and parental cell populations with unique interactive properties. We study different adaptive dosage strategies for PC3 and DU145 prostate cancer cell lines. We show that stronger doses of radiation given in longer time intervals, while keeping the overall dosage the same, reduce final tumor volume by more than half in PC3 cell lines, but by only five percent in DU145 cell lines. In addition, we tested an adaptive dosing schedule by administering a stronger dosage on Friday to compensate for the treatment-off period during the weekend, which was effective in decreasing the final tumor volume of both cell lines. This result creates interesting possibilities for new radiotherapy strategies at clinics that cannot provide treatment on weekends. Finally, we propose a dosage plan incorporating our findings.
Code
Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.
Code Syntology ran Syntology
Not run by Syntology. Nothing on this page verifies that the listed code works.
Results from the paper archive 2025-07-28
No leaderboard rows for this paper in the archive.
Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections